建立一个全系统的风险评估过程,对研究药物进行风险评估
Kevin Zinchuk1, Helen Volf1, Kay Li2
1Investigational Drug Service, Brigham and Women's Hospital, Boston, MA, USA.
概括
一个标准化药房主导的过程被开发,以评估危险药物风险的研究产品 (IPs),确保符合美国药典 (USP) 章节<800>. 该系统增强了学术卫生网络的安全性和监管遵守.
科学领域:
- 制药科学 制药科学
- 职业健康和安全问题 职业健康和安全问题
- 临床研究管理 临床研究管理
背景情况:
- 美国药典 (USP) 第800章要求危险药物管理,但缺乏针对研究产品 (IP) 的具体指导.
- 美国国家职业安全与健康研究所 (NIOSH) 的危险药物清单中已有过时的信息,为新兴药物创造了空白.
- 学术卫生网络需要标准化的方法来评估研究人员的风险.
研究的目的:
- 描述药房主导的研究产品 (IP) 风险评估 (AOR) 过程的开发和实施.
- 确保在一个大型的学术健康网络中遵守USP第800章标准.
- 建立一个一致和透明的系统来评估IPs的危险药物特性.
主要方法:
- 一个由药房服务部门领导的多学科工作组开发了一个全系统的IP AOR流程.
- 创建了两个不同的评估工具,包括小分子和生物制药剂的毒理学和生物安全标准.
- 为了保持一致性和监管合规性,建立了一个集中数据库和一个监督委员会.
主要成果:
- 截至2025年7月,已评估了255个专业项目:8个高风险危险项目,126个低风险危险项目,121个非危险项目.
- 该过程为IPs提供了适当的标签和安全处理程序.
- 对于管理IP的研究药房,建立了有效的审查工作流程.
结论:
- 药房主导的IP AOR流程对于对研究药物的USP<800>要求进行操作至关重要.
- 该模型增强了职业安全,监管合规性,并支持在卫生系统中可扩展的实施.
- 描述的过程可以适应新上市的药物,尚未由NIOSH审查.
相关概念视频
Clinical Trials: Overview
5.2K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.2K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
515
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
515
Preclinical Development: Overview
6.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.3K
Drug Regulation
3.2K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.2K
Pharmacovigilance
1.9K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
Clinical Trials
11.0K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
11.0K


